Evidence map›Paper›PMID 31678305›Full record

ReviewChest2020

Mobile Health Technologies in Cardiopulmonary Disease.

Grant E MacKinnon, Evan L Brittain

2 registry-linked trialsOpen access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Chest, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05893199 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Telemedicine in Atrial Fibrillation: Randomized Clinical Trial in Primary Care

TypeinterventionalSponsorUniversidad Miguel Hernandez de ElcheRan2023 to 2025Enrolled180ConditionsAtrial FibrillationArmsClinical monitoring using the Ti.Care app (https://ti.care/es), Usual care
NCT06217419 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Proof of Concept of Remote Management of Chronic Inflammatory Airway Diseases for Patient Empowerment

TypeinterventionalSponsorAzienda Ospedaliero Universitaria di SassariRan2024 to 2026Enrolled136ConditionsChronic Rhinosinusitis With Nasal Polyps, AsthmaArmsRadio Frequency IDentification (RFID) device
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Grant E MacKinnonVanderbilt University School of Medicine, Nashville, TN.
Evan L BrittainVanderbilt University Medical Center, Nashville, TN. Electronic address: evan.brittain@vumc.org.
Vanderbilt University · USVanderbilt University Medical Center · US

Funding

A Mobile Health Intervention in Pulmonary Arterial HypertensionR34HL136989 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BRITTAIN, EVAN L · 2017 to 2019
$719k
NHLBI NIH HHS R34 HL136989
6 · The paper itself

Abstract

Mobile health (mHealth) technologies are modernizing medicine by affording greater patient engagement, monitoring, outreach, and health-care delivery. The cardiopulmonary fields have led the integration of mHealth into clinical practice and research. mHealth technologies in these areas include smartphone applications, wearable devices, and handheld devices, among others, and provide real-time monitoring of numerous important physiological measurements and other key parameters. Use of mHealth-compatible devices has increased in recent years, and age and socioeconomic gaps of ownership are narrowing. These tools provide physicians and researchers with a better understanding of an individual's health and well-being. mHealth interventions have shown utility in the prevention, monitoring, and management of atrial fibrillation, heart failure, and myocardial infarction. With the growing prevalence of cardiopulmonary disease, mHealth technologies may become a more essential element of care within and outside of traditional health-care settings. mHealth is continuously developing as a result of technologic advancements and better understandings of mHealth utility. However, there is little regulation on the mHealth platforms available for commercial use and even fewer guidelines on implementing evidence-based practices into mHealth technologies. Online security is another challenge and necessitates development in data collection infrastructure to manage the extraordinary volume of patient data. Continued research on long-term implications of mHealth technology and the integration of effective interventions into clinical practice is required.

Indexed as

Cardiovascular DiseasesLung DiseasesMobile ApplicationsMonitoring, AmbulatorySmartphoneTelemedicineWearable Electronic DevicesAtrial FibrillationCardiac RehabilitationDecision Support Systems, ClinicalDisease ManagementEchocardiographyElectrocardiographyHeart FailureHumansMass Screeningcardiovascular diseasedigital healthmHealthmobile health

Identifiers

PMID31678305
PMCPMC7078586
OpenAlexW2982664489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.